Use of the ganglionic blocking agent pyrilene together with other hypotensive agents
Tikhonenko, V.M.; Kazak, L.I.
Vrachebnoe Delo 3: 19-21
1973
ISSN/ISBN: 0049-6804 PMID: 4733020 Document Number: 57597
Document emailed within 1 workday
Related Documents
Murata, K.; Ichikawa, S.; Sakamaki, T.; Matsuo, H. 1978: Hexamethonium and ganglionic blocking agents Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3593-3597Himori, N.; Izumi, A.; Hiramatsu, Y. 1976: Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs Archives Internationales de Pharmacodynamie et de Therapie 220(1): 4-18
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Péter, M.; Gyéresi, A.; Fülöp, F. 2001: Liquid chromatographic enantioseparation of beta-blocking agents with (1R,2R)-1,3-diacetoxy-1-(4-nitrophenyl)-2-propyl isothiocyanate as chiral derivatizing agent Journal of Chromatography A 910(2): 247-253
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Fisher, M.; Huangfu, D.; Shen, T.Y.; Guyenet, P.G. 1994: Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent Journal of Pharmacology and Experimental Therapeutics 270(2): 702-707
Nakahara, H.; Nakazawa, M.; Tsukada, T.; Imai, S. 1985: Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits Archives Internationales de Pharmacodynamie et de Therapie 277(2): 253-263
Kocemba, J.; Kawecka-Jaszcz, K.; Sniezek, M.; Augustyński, W.; Starzycka, M. 1977: Prazosin--a new hypotensive agent Kardiologia Polska 20(5): 381-387
Gilgenkrantz, J.M.; Hua, G.; Weiller, M.; Polu, J.M.; Mayer, G. 1971: A new hypotensive agent: FH109C. Apropos of 32 cases La Presse Medicale 79(4): 151-152
Warembourg, H.; Stalnikiewicz, G. 1970: Clinical study of hypotensive agent: Esimil Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 15(Suppl 5): 993-998
Ignat'ev, M.V. 1979: Hypotensive agents Fel'dsher i Akusherka 44(6): 41-43
Orlov, V.N. 1983: Hypotensive agents Klinicheskaia Meditsina 61(8): 128-134
Pretolani, E.; Biagioli, R.; Garaffoni, O. 1977: Clinical evaluation of a quinazoline-derivative hypotensive agent (prazosin or Minipress) Bollettino Della Societa Italiana di Cardiologia 22(9): 1507-1514
Horák, O. 1970: Adverse effects of hypotensive agents Casopis Lekaru Ceskych 109(41): 969-972
Ulmer, W.T.; Dorsch, J.; Iravani, J.; Schüler, K.G.; Stempel, G.; Vastag, E. 1973: Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction Arzneimittel-Forschung 23(3): 468-476
Candau, L.A.; Tasca, R.; Carvalho, D.M.; Scherr, C. 1981: Action of verapamil as a hypotensive agent - analysis of the arterial pressure curve in the cycloergometric test Arquivos Brasileiros de Cardiologia 36 Suppl. 1: 18-23
Nathanson, J.A. 1992: Nitrovasodilators as a new class of ocular hypotensive agents Journal of Pharmacology and Experimental Therapeutics 260(3): 956-965